ภาษาไทย Español Português 한국어 简体中文 繁體中文 日本語 Tiếng Việt Bahasa Indonesia Монгол ئۇيغۇر تىلى العربية Русский हिन्दी
BoJ Rate Decision at 1%: Why Japan’s Historic Rate Hike Has Left the Yen Behind
BoJ Rate Decision at 1%: Why Japan’s Historic Rate Hike Has Left the Yen Behind
2026-06-18
BoJ at 1% marks Japan’s historic rate shift, but the yen remains weak as the Fed-BoJ yield gap keeps USD/JPY carry demand intact.
Defiance Autism Impact ETF: 7 Things to Know About the First Autism-Focused ETF
Defiance Autism Impact ETF: 7 Things to Know About the First Autism-Focused ETF
2026-06-18
Learn what the Defiance Autism Impact ETF holds, how its impact pledge works, and why assets, fees and liquidity matter for ASD.
MU Stock Before June 24: 10x Forward P/E, Third in HBM4, $200B Capex Cycle
MU Stock Before June 24: 10x Forward P/E, Third in HBM4, $200B Capex Cycle
2026-06-16
Micron Q2 margins hit 74.4%. Q3 guidance is $33.5B at 81%. The 10x forward P/E and HBM4 positioning define what June 24 earnings reveal.
Is the Stock Market Open on Juneteenth 2026? June 19 Closes Stocks, Bonds and Futures
Is the Stock Market Open on Juneteenth 2026? June 19 Closes Stocks, Bonds and Futures
2026-06-16
Is the stock market open on Juneteenth 2026? See June 19 hours for stocks, bonds and futures, plus settlement and liquidity risks.
Kardigan IPO: 8 Things to Know Before KARD’s $1.4B Nasdaq Debut
Kardigan IPO: 8 Things to Know Before KARD’s $1.4B Nasdaq Debut
2026-06-16
Kardigan IPO details: KARD’s $14-$16 Nasdaq debut, $1.3B-$1.4B valuation, 2027 trial catalysts, and key risks to watch.
Vedanta Demerger Explained: Can 5 New Stocks Unlock More Value?
Vedanta Demerger Explained: Can 5 New Stocks Unlock More Value?
2026-06-16
Vedanta demerger explained: 5 new stocks, VAML’s first-day test, and whether the 20% value gap can survive real trading.
ASML Stock at 48x Forward Earnings: The AI Bottleneck Trade Needs Proof
ASML Stock at 48x Forward Earnings: The AI Bottleneck Trade Needs Proof
2026-06-15
ASML remains critical to advanced chip production, but valuation, EUV demand, High-NA adoption, and order growth now define the risk-reward.
Highest Gold Price Ever: Why Gold Hit $5,600 Faster Than Past Cycles
Highest Gold Price Ever: Why Gold Hit $5,600 Faster Than Past Cycles
2026-06-15
Gold hit a record near $5,600 in January 2026. See why demand, ETF flows and faster gold cycles made this record different.
NVIDIA vs AMD Stock: Why AMD Is Not the Cheaper AI Entry Despite Nvidia's $75B Lead
NVIDIA vs AMD Stock: Why AMD Is Not the Cheaper AI Entry Despite Nvidia's $75B Lead
2026-06-15
Nvidia vs AMD stock comparison for 2026, covering AI chip demand, data center growth, valuation risk, entry points, and ETF exposure.
How Much Does Elon Musk Makes A Day?
How Much Does Elon Musk Makes A Day?
2026-06-15
Elon Musk net worth hit about $1.1 trillion in 2026. See how much he makes per day, from 2025 averages to the SpaceX IPO jump.
Nikkei 225 Forecast: Is the Run to 70,000 an Entry Point or the Top?
Nikkei 225 Forecast: Is the Run to 70,000 an Entry Point or the Top?
2026-06-15
Nikkei 225 forecast: can the run to 70,000 hold? Key levels, 76,000 base case, BOJ risk, oil relief and AI momentum explained.
Where and How to Trade SpaceX Stock (SPCX) Without a US Broker
Where and How to Trade SpaceX Stock (SPCX) Without a US Broker
2026-06-12
SpaceX (SPCX) listed on Nasdaq June 12, 2026 at $135. Trade the world’s biggest IPO as a CFD from $50 through EBC, fees waived, no US account required.
What Is MANGOS? The 6 AI Giants Redefining Big Tech After FAANG
What Is MANGOS? The 6 AI Giants Redefining Big Tech After FAANG
2026-06-12
MANGOS explained: how Meta, Anthropic, Nvidia, Google, OpenAI and SpaceX are redefining Big Tech after FAANG.
SanDisk Stock Split? 5 Signals to Watch in 2026 as SNDK Nears $2,000
SanDisk Stock Split? 5 Signals to Watch in 2026 as SNDK Nears $2,000
2026-06-12
SanDisk stock split speculation rises as SNDK nears $2,000. Here are five 2026 signals that could turn split talk into corporate action.
Eli Lilly Stock Outlook 2026: The Retatrutide Upgrade Cycle
Eli Lilly Stock Outlook 2026: The Retatrutide Upgrade Cycle
2026-06-12
Eli Lilly stock outlook 2026: retatrutide opens the next GLP-1 efficacy cycle as the gap with Novo Nordisk widens, against net pricing and a premium valuation.